Comparison of the acute effects of salbutamol and terbutaline on heart rate variability in adult asthmatic patients

Eryonucu B., Uzun K., Guler N., Bilge M.

Source: Eur Respir J 2001; 17: 863-867
Journal Issue: May
Disease area: Airway diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Eryonucu B., Uzun K., Guler N., Bilge M.. Comparison of the acute effects of salbutamol and terbutaline on heart rate variability in adult asthmatic patients. Eur Respir J 2001; 17: 863-867

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of inhaled salbutamol on autonomic control of heart rate in patients with bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 58s
Year: 2002

Reduced heart rate variability in chronic bronchial asthma with steroid dependency
Source: Eur Respir J 2004; 24: Suppl. 48, 508s
Year: 2004

The effect of high dose bronchodilators on cardiac function in elderly people with severe COPD or asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 407s
Year: 2002

Inhaled anticholinergics affect the heart rate recovery in stable COPD patients
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018


Influence of resistance training on heart rate variability in the difficult-to-control asthmatic patients.
Source: Virtual Congress 2020 – Novel insights into exercise training
Year: 2020


Interindividual variability of peak inhalation rate through different inhalers by asthmatic children and adults and those with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 133s
Year: 2001

Changes of heart rate variability in different types of breathing in patients with bronchial asthma (BA)
Source: Eur Respir J 2001; 18: Suppl. 33, 34s
Year: 2001

Effects of long-acting inhaled β-adrenergic and anticholinergic drugs on respiratory function and arterial blood gases in patients with COPD
Source: Annual Congress 2006 - Recent advances in the treatment of COPD
Year: 2006


A preliminary study to determine the effects of nebulised salbutamol on blood glucose levels during an acute asthma exacerbation.
Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Year: 2019


Efficacy and safety of salmeterol in patients with bronchial asthma (BA) and ischemic heart disease (IHD)
Source: Eur Respir J 2002; 20: Suppl. 38, 57s
Year: 2002

Influence of non-medicamentous methods of treatment on heart rate variability (HRV) at patients with bronchial asthma (BA)
Source: Eur Respir J 2005; 26: Suppl. 49, 183s
Year: 2005

High doses inhaled salbutamol by MDI in patients with acute bronchial asthma and its cardiopulmonary effects
Source: Annual Congress 2009 - Aspects of uncontrolled asthma
Year: 2009

The effect of noninvasive ventilation on heart rate variability in COPD patients with hypercapnic respiratory failure
Source: Annual Congress 2007 - Clinical applications of noninvasive ventilation
Year: 2007


Effects of salmeterol on heart rate variability in patients with bronchial asthma and coronary artery disease
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008


Treatment of acute asthma
Source: Eur Respir Mon 2012; 56: 172-187
Year: 2012


Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD
Source: Eur Respir J 2007; 29: 1115-1119
Year: 2007



Frequency of acute flow and volume responses to bronchodilator administration in patients with COPD
Source: Annual Congress 2007 - Treatment and care of COPD
Year: 2007


NVA237, a once-daily anticholinergic, demonstrates sustained bronchodilation and is well tolerated in patients with reversible obstructive airways disease
Source: Annual Congress 2006 - Recent advances in the treatment of COPD
Year: 2006


High or standard initial dose of budesonide to control mild-to-moderate asthma?
Source: Eur Respir J 2001; 17: 856-862
Year: 2001



Severe exacerbations, decline in lung function and inhaled budesonide in asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 619s
Year: 2007